Spelling suggestions: "subject:"adenoma plein?rficos"" "subject:"adenoma plein?rfic""
1 |
Imunoexpress?o da prote?na endonuclease apur?nica/apurimid?nica (APE-1) em adenomas pleom?rficos e carcinomas ex-adenomas pleom?rficosSilva, Leorik Pereira da 19 February 2016 (has links)
Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-07-11T17:13:30Z
No. of bitstreams: 1
LeorikPereiraDaSilva_DISSERT.pdf: 1755248 bytes, checksum: 7c7295f3b5a7cf31b5ae4aa23ab61afd (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-07-14T22:02:14Z (GMT) No. of bitstreams: 1
LeorikPereiraDaSilva_DISSERT.pdf: 1755248 bytes, checksum: 7c7295f3b5a7cf31b5ae4aa23ab61afd (MD5) / Made available in DSpace on 2016-07-14T22:02:14Z (GMT). No. of bitstreams: 1
LeorikPereiraDaSilva_DISSERT.pdf: 1755248 bytes, checksum: 7c7295f3b5a7cf31b5ae4aa23ab61afd (MD5)
Previous issue date: 2016-02-19 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (CAPES) / Introdu??o: A endonuclease apur?nica/apurimid?nica (APE-1) ? uma prote?na essencial para a via do reparo por excis?o de bases (BER) do DNA, al?m de regula??o de atividades redox. A capacidade de c?lulas malignas em reconhecer e reparar danos no DNA ? um mecanismo importante para sobreviv?ncia tumoral, e estudos recentes sugerem que a superexpress?o da APE-1 pode se relacionar com o pobre progn?stico em alguns tumores. Objetivo: Analisar a imunoexpress?o da APE-1 em Adenomas Pleom?rficos (AP) e Carcinomas Ex-Adenomas Pleom?rficos (CaExAP) de gl?ndulas salivares. Materiais e M?todos: Foram selecionados 49 tumores fixados em formol e inclu?dos em parafina (33 AP e 16 CaExAP) que foram submetidos a estudo imuno-histoqu?mico pela t?cnica da imunoperoxidase. A imunoexpress?o da APE-1 foi avaliada de forma quantitativa pelo percentual de c?lulas imunopositivas. Para an?lise estat?stica foi adotado n?vel de signific?ncia de 5% (p ? 0,05). Resultados: Todos os casos de AP e CaExAP (n=49) foram positivos para APE-1, no entanto, houve maior express?o em CaExAP havendo diferen?a estatisticamente relevante (p<0,001). N?o foi encontrada associa??o da express?o da APE-1 entre tumores de gl?ndula salivar maior ou menor, entretanto, em AP n?o encapsulados (Mediana de express?o= 54,2%) houve maior express?o quando comparados a tumores encapsulados (p=0,02). A superexpress?o da APE-1 foi constatada principalmente em casos de CaExAP com met?stase linfonodal (Mediana de express?o= 90,3% - p=0,002) e padr?o invasivo (Mediana de express?o= 89,9% - p=0,003) quando comparados aos casos sem met?stase e intracapsulares. Conclus?o: Este estudo sugere que a APE-1 encontra-se desregulada nos tumores estudados. A maior express?o da APE-1 est? associada com a aus?ncia de c?psula completa em AP e a superexpress?o est? relacionada com o comportamento mais agressivo do CaExAP. / Introduction: Apurinic/Apyrimidinic Endonuclease 1 (APE-1) is an essential protein for DNA base excision repair (BER) pathway and regulation of redox activities. The ability of malignant cells to recognize and repair DNA damage is an important mechanism for tumor survival, and recent studies suggest that APE-1 overexpression is related to poor prognosis in some tumors. Purpose: To analyze the immunoreactivity of APE-1 in Pleomorphic Adenomas (PA) and Carcinomas Ex Pleomorphic Adenomas (CaExPA) of salivary glands. Materials and Methods: A total of 49 tumors fixed in formalin and embedded in paraffin (33 PA and 16 CaExPA) underwent immunohistochemical study by the immunoperoxidase technique. APE-1 immunoreactivity was evaluated quantitatively by the percentage of immunopositive cells. For statistical analysis a significance level of 5% (p? 0.05) was adopted. Results: All cases of PA and CaExPA (n=49) were positive for APE-1, however, there was a higher expression in CaExPA, with statistically significant difference (p<0.001). There was no association between APE-1 expression and tumors of major or minor salivary gland, however, not encapsulated PA (median expression = 54.2%) showed higher expression when compared to encapsulated tumors (p=0.02). APE-1 overexpression was found mainly in cases of CaExAP with lymph node metastasis (median expression = 90.3% - p=0.002) and invasive pattern (median expression = 89.9% - p=0.003), when compared to cases without metastasis and intracapsular pattern. Conclusion: This study suggests that APE-1 is deregulated in the studied tumors. The increased expression of APE-1 is associated with the absence of complete capsule in PA and it is associated with more aggressive behavior in CaExPA.
|
2 |
Altera??es nos genes da E-caderina e ?-catenina em adenoma pleom?rfico e carcinoma aden?ide c?stico: estudo molecular e imuno-histoqu?mico / Alterations of E-cadherin and ?-catenin genes in pleomorphic adenoma and adenoid cystic carcinoma: molecular and immunohistochemical studyCavalcante, Roberta Barroso 30 August 2008 (has links)
Made available in DSpace on 2014-12-17T15:32:27Z (GMT). No. of bitstreams: 1
RobertaBC.pdf: 1065704 bytes, checksum: 6e6f9aa3d97c1150d7b5fd4167469597 (MD5)
Previous issue date: 2008-08-30 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Pleomorphic adenoma and adenoid cystic carcinoma represent a benign and malignant salivary gland neoplasm, respectively, that shares the same histological origin, however with distinct biological behavior. The aim of the present study was identify the -160 C/A
polymorphism in the gene CDH1, mutational analysis of CTNNB1 gene and evaluation the expression of the E-cadherin and ?-catenin in pleomorphic adenomas and adenoid cystic carcinomas. Furthermore, it was proposed correlate the immunochemistry staining patterns with the polymorphism and mutations. Twenty-four pleomorphic adenomas and 24 adenoid
cystic carcinomas were retrieved. The polymorphism analysis was performed by restriction fragment length polymorphism (RFLP), using the restriction enzymes HphI or AflIII and the mutational screening was performed by PCR-single strand conformational polymorphism
(PCR-SSCP). The immunohistochemical analysis was taken by the counting of cells, recorded as the Hscore index, and considering the presence or absence, intensity, distribution and localization of proteins expression. Comparing the two neoplasms, the results demonstrated statistically significant difference for the E-cadherin and ?-catenin expression, with pleomorphic adenoma presenting weaker immunostaining. Was observed statistical correlation between E-cadherin and ?-catenin expression. CDH1 heterozigotic polymorphism was seen in two cases and 13 cases displayed abnormal mobility electrophoretic shifts, suggesting CTNNB1 gene mutation. The immunohistochemical expression was not statistically correlated with the polymorphism or suggested mutations. In conclusion this study supports that the E-cadherin/?-catenin complex immunohistochemical expression might be related with the myoepithelial component amount and differentiation neither the tumor biological behavior. The cases that showed E-cadherin gene polymorphism presented
reduced protein expression and, moreover, CTNNB1 suggested mutations seem not influence in the ?-catenin protein expression / O adenoma pleom?rfico e o carcinoma aden?ide c?stico representam neoplasias de gl?ndula salivar benigna e maligna, respectivamente, que compartilham a mesma origem histol?gica, por?m com comportamentos biol?gicos distintos. O prop?sito deste estudo consistiu na identifica??o do polimorfismo -160 C/A da regi?o promotora do gene CDH1 (E-caderina), na triagem de muta??es no gene CTNNB1 (?-catenina), e ainda na an?lise da express?o imuno-histoqu?mica das prote?nas E-caderina e ?-catenina em adenomas pleom?rficos e carcinomas aden?ides c?sticos. Al?m disso, objetivou-se correlacionar os achados imuno-histoqu?micos com
as poss?veis muta??es e polimorfismo. Foram selecionados 24 casos de adenoma pleom?rfico e 24
casos de carcinoma aden?ide c?stico. Para a identifica??o do polimorfismo no gene da E-caderina empregou-se a t?cnica RFLP (restriction fragment length polymorphism) utilizando-se enzimas de restri??o HphI e AflIII. A triagem de muta??es no exon 3 do gene da ?-catenina foi realizada por meio de SSCP (single strand conformational polymorphism). Para a an?lise imuno-histoqu?mica,
procedeu-se contagem de c?lulas, por meio do ?ndice HScore e verificou-se presen?a ou aus?ncia, intensidade, padr?o de distribui??o e localiza??o celular e tecidual das prote?nas. Os resultados demonstraram diferen?a estatisticamente significativa quando a marca??o imuno-histoqu?mica, tanto da E-caderina quanto ?-catenina, foi comparada entre as duas neoplasias estudadas, apresentando o adenoma pleom?rfico express?o reduzida. Observou-se correla??o estatisticamente significativa entre a imuno-marca??o da E-caderina e ?-catenina. Dois casos (1 adenoma pleom?rfico e 1 carcinoma aden?ide c?stico) apresentaram polimorfismo heterozig?tico no gene CDH1 e 13 casos (6 adenomas pleom?rficos e 7 carcinomas aden?ides c?sticos) exibiram varia??o no padr?o de corrida eletrofor?tica, sugerindo muta??o do gene CTNNB1. N?o houve
correla??o estatisticamente significativa entre a marca??o imuno-histoqu?mica e presen?a de polimorfismo ou poss?veis muta??es. Conclui-se que a express?o imuno-histoqu?mica do complexo E-caderina/?-catenina pode estar relacionada com a quantidade e diferencia??o do componente mioepitelial e n?o ao comportamento biol?gico dos tumores. Os casos que exibiram polimorfismo no gene da E-caderina apresentaram redu??o na express?o prot?ica e, por fim, as poss?veis muta??es no gene CTNNB1 parecem n?o influenciar na express?o da prote?na ?-catenina
|
3 |
Estudo da express?o imuno-histoqu?mica das MMPs -2, -7, -9 e -26 e TIMPs -1 e -2 em adenomas pleom?rficos e carcinomas aden?ides c?sticos de gl?ndulas salivares menoresFreitas, Val?ria Souza 24 February 2011 (has links)
Made available in DSpace on 2014-12-17T15:32:30Z (GMT). No. of bitstreams: 1
ValeriaSF_TESE.pdf: 1554906 bytes, checksum: 59273626aa3c7c32d790e22ae6dd68d4 (MD5)
Previous issue date: 2011-02-24 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / The balance between the expression of matrix metalloproteinases (MMPs) and their
tissue inhibitors (TIMPs) has been related to various physiological and pathological
processes, including salivary gland morphogenesis and tumor invasion and metastasis
processes. Pleomorphic adenoma (PA) and adenoid cystic carcinoma (ACC) respectively
represent benign and malignant neoplasias of salivary glands. Although they share the same
cell origin, they present distinct biological behavior. The aim of this study was to compare the
immunohistochemical expression of MMPs -2, -7, -9 and -26, and of TIMPs -1 and -2, in
cases of PA and ACC of minor salivary glands. Twenty cases of PA and twenty cases of ACC
were assessed according to the presence, intensity and location of MMPs and TIMPs in the
tumor parenchyma. Most of the PAs and ACCs presented a high expression of MMP -2, -7, -9
and -26 and of TIMP -1 and -2, predominantly located in tumor cells. There was no
significant difference in the expression of MMPs -2 (p=0.359), -7 (p=0.081) and -26
(p=0.553), as well as of TIMPs -1 (p=0.657) and -2 (p=0.248), between the parenchyma of
PAs and ACCs. However, MMP-9 showed a significant difference of expression between the
two tumors, with the ACC showing more intense marking for this gelatinase (p=0.041). The
strong expression of MMP-9 observed in the parenchyma suggests that this gelatinase may
play an important role in the biological behavior of these tumors. On the other hand, although
there was no significant difference between the marking of MMP -2, 7 and 26 in the studied
tumors, the data, when analyzed as a whole, suggest that these proteases may take part in the
process of tissue remodeling in both tumors, but do not present a direct relation with the
pattern of aggressiveness of ACC. Nonetheless, matrilisins may indirectly influence the
behavior of this tumor due to their capacity of activating MMP-9, strongly expressed in the
parenchyma of ACC / O balan?o entre a express?o das metaloproteinases da matriz (MMPs) e seus inibidores
teciduais (TIMPs) tem sido relacionado a v?rios processos fisiol?gicos e patol?gicos,
incluindo a morfog?nese de gl?ndulas salivares e os processos de invas?o e met?stase
tumoral. O adenoma pleom?rfico (AP) e o carcinoma aden?ide c?stico (CAC) representam,
respectivamente, neoplasias benignas e malignas de gl?ndulas salivares que, embora
compartilhem a mesma origem celular, apresentam comportamentos biol?gicos distintos. O
prop?sito deste estudo foi comparar a express?o imuno-histoqu?mica das MMPs -2, -7, -9 e -
26 e dos TIMPs -1 e -2 em casos de AP e CAC de gl?ndulas salivares menores. Vinte casos
de AP e vinte casos de CAC foram avaliados quanto ? presen?a, intensidade e localiza??o das
MMPs e TIMPs no par?nquima tumoral. A maioria dos APs e CACs apresentaram alta
express?o das MMPs e dos TIMPs, predominantemente localizada nas c?lulas tumorais. N?o
houve diferen?a estatisticamente significativa na express?o das MMPs -2 (p=0,359), -7
(p=0,081) e -26 (p=0,553), bem como dos TIMPs -1 (p=0,657) e -2 (p=0,248), entre o
par?nquima dos APs e CACs. A MMP-9 demonstrou uma diferen?a significativa de express?o
entre os dois tumores, apresentando o CAC uma marca??o mais intensa para esta gelatinase
(p=0,041). A forte express?o da MMP-9 observada no par?nquima dos CACs sugere que esta
gelatinase possa desempenhar um papel importante no comportamento biol?gico destes
tumores. Por outro lado, apesar de n?o ocorrer uma diferen?a significativa entre as m?dias das
MMPs -2, 7 e 26 nos tumores estudados, os dados quando analisados em conjunto sugerem
que estas proteases podem estar participando de processos de remodela??o tecidual em ambos
os tumores, mas n?o apresentam uma rela??o direta com o padr?o de agressividade do CAC.
Entretanto, as matrilisinas poderiam influenciar indiretamente o comportamento deste tumor
devido a sua capacidade de ativar a MMP-9, fortemente expressa no par?nquima destes
tumores
|
4 |
Express?o imuno-histoqu?mica das integrinas a2?1, a3?1 e a5?1 em adenoma pleom?rfico de gl?ndula salivar menor e maior e carcinoma aden?ide c?stico / Immunohistochemical expression of D2E1, D3E1 e D5E1 integrins in pleomorphic adenoma from minor and major salivary glands and adenoid cystic carcinomaMiguel, M?rcia Cristina da Costa 27 May 2005 (has links)
Made available in DSpace on 2014-12-17T15:32:33Z (GMT). No. of bitstreams: 1
MarciaCCMiguel_tese.pdf: 1534160 bytes, checksum: 1a3ec415bfaf10c088ec1ae5f6224189 (MD5)
Previous issue date: 2005-05-27 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / Pleomorphic adenoma and adenoid cystic carcinoma (ACC) consist benign and malignant neoplasm from salivary gland, respectively. These neoplasms share some characteristics, such as cellular origin and considerable production of extracellular matrix, however, with distinct biological behavior. The aim of the present study was to compare the expression of D2E1, D3E1 e D5E1 integrins in pleomorphic adenoma from minor and major salivary glands and ACCs. Furthermore, it was investigated possible differences in the expression of these integrins according to histological subtypes of ACC. Fourteen cases of pleomorphic adenoma from major salivary gland, fourteen cases from minor salivary gland and ten cases of ACC were selected. It was taken into consideration the presence or absence, localization and intensity of integrin immunoexpression. The cases of pleomorphic adenoma were grouped in order to compare the expression between the distinct neoplasms. It was observed a highly significant difference (p<0,0001) in relation to D2E1 integrin between the neoplasms since pleomorphic adenoma showed a pronounced immunostaining. It was not possible to perform statistical tests considering the D2E1 integrin expression; nevertheless, it could be observed a tendency of higher staining in pleomorphic adenoma. For comparative reasons the cases ACCs were divided in two groups: solid and tubular/cribriform. It was not detected significant differences in regard to D2E1 integrin; and statistical analysis could not be realized in relation to D3E1 and D5E integrin expression. However, it was also verified a tendency of absence or reduced expression in the solid subtype. It can be concluded that the reduced D2E1 integrin expression observed in CACs may be related to a lesser degree of cell differentiation in this neoplasm and the reduced D5E1 integrin expression can be associated with aggressive biological behavior. Moreover, the absence and/or reduced expression of the studied integrins in solid ACC suggests a role in pathogenesis and more aggressive biological behavior of this histological subtype / O adenoma pleom?rfico e o carcinoma aden?ide c?stico (CAC) representam neoplasias de gl?ndula salivar benigna e maligna, respectivamente, as quais compartilham algumas caracter?sticas como a mesma origem celular e uma marcante presen?a de matriz extracelular, apresentando, por?m, comportamentos biol?gicos distintos. O prop?sito desta pesquisa consistiu em comparar a express?o das integrinas D2E1, D3E1 e D5E1 em adenomas pleom?rficos de gl?ndula salivar menor e maior e CACs. Al?m disso, procurou investigar se havia diferen?as na express?o destas integrinas entre os subtipos histopatol?gicos do CAC. Foram selecionados 14 casos de adenoma pleom?rfico de gl?ndula salivar maior, 14 casos de gl?ndula salivar menor e 10 casos de CACs. Analisou-se a presen?a ou aus?ncia, localiza??o e intensidade de marca??o das integrinas. Os dois grupos de adenomas pleom?rficos foram reunidos em um s? para fazer a compara??o entre os dois tumores. Verificou-se que houve diferen?a estat?stica altamente significativa (p<0,0001) para a integrina D2E1 entre os dois tumores, apresentando o adenoma pleom?rfico, uma marca??o mais intensa para esta integrina. Em rela??o ? integrina D5E1 n?o foi poss?vel a realiza??o de testes estat?sticos, ficando patente, por?m, que houve uma tend?ncia da referida integrina ser mais intensamente expressa no adenoma pleom?rfico. Para an?lise comparativa, os CACs foram subdivididos em 2 grupos: s?lido e tubular/cribriforme. Para a integrina D2E1 observou-se que n?o houve diferen?a estatisticamente significativa e em rela??o ? D3E1 e D5E1 n?o foi poss?vel a realiza??o do teste estat?stico; no entanto, tamb?m foi verificada uma clara tend?ncia para os casos do subtipo s?lido apresentarem express?o ausente ou reduzida das integrinas avaliadas. Concluiu-se que a reduzida express?o da integrina D2E1 observada nos CACs, pode estar relacionada com a menor diferencia??o das c?lulas deste tumor e ? poss?vel que a reduzida express?o da D5E1, possa estar implicada em seu comportamento mais agressivo. Al?m disso, sugere-se que a aus?ncia e/ou redu??o da express?o das integrinas pesquisadas nos casos do subtipo s?lido, pode desempenhar algum papel na patog?nese e no comportamento biol?gico mais agressivo deste subtipo tumoral
|
5 |
Estudo imuno-histoqu?mico da express?o da GLUT-1 e mensura??o do ?ndice angiog?nico (CD34) em adenomas pleom?rficos, carcinomas aden?ides c?sticos e carcinomas mucoepiderm?ides de gl?ndulas salivaresOliveira, Lucileide Castro de 27 June 2012 (has links)
Made available in DSpace on 2014-12-17T15:32:22Z (GMT). No. of bitstreams: 1
LucileideCO_DISSERT.pdf: 2248988 bytes, checksum: f9aafad24354c13fb349a052f5b90d8e (MD5)
Previous issue date: 2012-06-27 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / The expression of glucose transporter protein 1 (GLUT-1), as well the angiogenesis has been associated to clinical behavior and aggressiveness in tumors of various origin. It is believed that the expression of this protein denotes metabolic demand of the tumor cells and, thus its influence upon the formation of new blood vessels. Pleomorphic adenoma (PA) and the adenoid cystic carcinoma (ACC) and mucoepidermoid carcinoma (MEC) represent, respectively, the most commom benign and malignant tumors of salivary glands. The aim of this study was to analyze and compare the immunohistochemical expression of GLUT-1 and its correlation with angiogenesis in cases of PAs, ACCs and MECs considering their histological grades. The sample consisted of 20 PAs, 20 ACCs and 10 MECs. The cases were analyzed and classified according to their histological grades. The expression of GLUT-1 was evaluated in the parenchyma lesions, establishing the percentage of immunopositive cells, according to the following scores: 0 (no cell immunomarked), 1 (up to 25% of tumor cells immunostained), 2 (25 - 50% of tumor cells immunostained) and 3 (more than 50% of tumor cells immunostained). The angiogenic index was analyzed by counting the microvessels immunostained by anti-CD34 antibody, in 5 fields (200X). The analysis of the expression of GLUT-1 in tumor parenchyma showed statistically significant differences between benign and malignant groups (p = 0.022). The average number of microvessels in PAs was 40.4, 21.2 in ACCs and 66.5 in MECs, with significant differences between groups (p <0.001). When compared to the expression of GLUT-1 and angiogenic index as a whole, there was no significant correlation between the number of microvessels and the expression of GLUT-1 (r = 0.211, p = 0.141). In conclusion, the results of this study suggest not only that differences in biological behavior between PAs, ACCs and MECs may be associated to the expression of GLUT-1, but also that benign and malignant salivary gland present differences in the average number of microvessels, with higher levels considered more aggressive tumors. Furthermore, the number of newly formed microvessels can be independent of the metabolic demand of the tumor cells / A express?o da prote?na transportadora de glicose tipo 1 (GLUT-1), bem como a angiog?nese, t?m sido relacionadas ao comportamento cl?nico e agressividade em neoplasias de origem diversas. Acredita-se que a express?o desta prote?na denote a demanda metab?lica das c?lulas tumorais e, assim, a sua influ?ncia na forma??o de novos vasos sanguineos. O adenoma pleom?rfico (AP) e o carcinoma adenoide c?stico (CAC) e carcinoma mucoepiderm?ide (CME) representam, respectivamente, a neoplasia benigna e as malignas mais frequentes das gl?ndulas salivares. O prop?sito deste estudo foi comparar a express?o imuno-histoqu?mica da GLUT-1, bem como correlacionar com a angiog?nese em casos de APs, CACs e CMEs levando em considera??o suas grada??es histol?gicas. A amostra foi composta por 20 APs, 20 CACs e 10 CMEs os quais foram classificados de acordo com os graus histol?gicos apresentados. A express?o da GLUT-1 foi avaliada no par?nquima das les?es, estabelecendo-se o percentual de c?lulas imunopositivas, de acordo com os escores: 0 (nenhuma c?lula imunomarcada), 1 (at? 25% das c?lulas tumorais imunomarcadas), 2 (de 25-50% das c?lulas tumorais imunomarcadas) e 3 (mais de 50% das c?lulas tumorais imunomarcadas). O ?ndice angiog?nico foi analisado por meio da contagem de microvasos imunomarcados pelo anticorpo anti-CD34, em 5 campos (200x). A an?lise da express?o da GLUT-1 revelou diferen?as estatisticamente significativas entre os grupos benignos e malignos (p = 0,022). O n?mero m?dio de microvasos foi de 40,4 em APs, 21,2 em CACs e 66,5 em CMEs, com diferen?as significativas entre os grupos (p < 0,001). Quando comparadas a express?o da GLUT-1 com o ?ndice angiog?nico em conjunto, n?o foi evidenciada correla??o significativa entre a quantidade de microvasos e a express?o da GLUT-1 (r = 0,211; p = 0,141). Os resultados do presente estudo sugerem que as diferen?as no comportamento biol?gico entre APs, CACs e CMEs podem estar relacionadas ? express?o da GLUT-1 e que tumores benignos e malignos de gl?ndulas salivares exibem diferen?as no n?mero m?dio de microvasos, com maiores ?ndices nos tumores considerados mais agressivos. Al?m disto, o n?mero de microvasos neoformados pode ser independente da demanda metab?lica das c?lulas tumorais
|
Page generated in 0.0611 seconds